what is ketamine

What is Ketamine?

Ketamine was first recognized for its anesthetic qualities, a medication that has been gaining attention for its potential therapeutic benefits. In recent years, it has been used as a treatment for various mental health conditions, including depression, anxiety, and post-traumatic stress disorder (PTSD). One of the main benefits of ketamine is its fast-acting nature. Unlike traditional antidepressant medications, which can take weeks or even months to take effect, ketamine can start to alleviate symptoms within hours. Grunebaum (2018) found that this rapid onset of action can be particularly beneficial for individuals who are experiencing severe depression or suicidal thoughts.

So how does ketamine work? Ketamine is an N-methyl-D-aspartate or NMDA receptor antagonist, which means it blocks the action of the NMDA receptors in the brain. In 2016, Zorumski found that it increases the levels of a neurotransmitter called glutamate, which is believed to play a role in mood regulation. Additionally, ketamine also activates another pathway in the brain called the mammalian target of rapamycin or mTOR pathway, which is involved in the growth and maintenance of neurons. These mechanisms are thought to contribute to ketamine’s antidepressant and anti-anxiety effects.

In terms of what ketamine can treat, it has shown promising results in various studies. Apart from depression and anxiety disorders, recent research has shown that ketamine has been investigated as a treatment for bipolar disorder, obsessive-compulsive disorder (OCD), and even chronic pain conditions (Kraus et al., 2019). However, it is important to note that more research is needed to fully understand the effectiveness and safety of ketamine for these conditions.

In conclusion, ketamine has been known as a potential therapeutic alternative for those with mental health issues. It’s a possible substitute for traditional medications for depression because of its distinct methods of action and quick start of effect. However, because of its possible negative effects and misuse potential, ketamine must be taken under proper medical supervision. When thinking about ketamine as a therapeutic option, it’s critical to speak with medical specialists and depend on evidence-based information since this field of study continues to develop.

Kraus, C., Wasserman, D., Henter, I.D., Acevedo-Diaz, E., Kadriu, B., & Zarate, C. A. Jr (2019). The influence of ketamine on drug discovery in depression. Drug Discovery Today, 24(10), 2033–2043. https://doi.org/10.1016/j.drudis.2019.07.007

Grunebaum, M. F., Galfalvy, H. C., Choo, T. H., Keilp, J. G., Moitra, V. K., Parris, M. S., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., Oquendo, M. A., & Mann, J. J. (2018). Ketamine for rapid reduction of suicidal thoughts in major depression: A midazolam-controlled randomized clinical trial. American Journal of Psychiatry, 175(4), 327-335. https://doi.org/10.1176/appi.ajp.2017.17060647

Zorumski, C.F., Izumi, Y., & Mennerick, S. (2016). Ketamine: NMDA Receptors and beyond. Journal of Neuroscience, 36(44), 11158-11164. https://doi.org/10.1523/JNEUROSCI.1547-16.2016

Scroll to Top